Global Macular Degeneration Treatment Market Size, Industry Trends, Share and Forecast - 2020-2026

The global macular degeneration treatment market is estimated to grow at a CAGR of nearly 7.0% during the forecast period. The major factors contributing to the market growth include a significant rise in the prevalence of age-related macular degeneration (AMD) and rising geriatric population base. As per the International Agency for the Prevention of Blindness (IAPB), AMD is the third most common cause of blindness across the globe. It is the major cause of blindness in higher-income countries with geriatric populations. AMD accounts for nearly 5% of blindness across the globe. The major risk factors that lead to the rising incidences of AMD include genetic factors, age, and tobacco smoking.

Request a free sample of our report on Global Macular Degeneration Treatment Market: https://www.omrglobal.com/request-sample/macular-degeneration-treatment-market

AMD is the major cause of permanent central vision loss among people aged 65 and over in developed countries. The incidence of macular degeneration is expected to rise continuously coupled with the significant rise in ageing population. This, in turn, will drive the demand for reliable and effective macular degeneration treatment. The treatment efforts for AMD is aimed to keep the central vision as long as possible. The treatment alternatives available for wet AMD include Bevacizumab (Avastin), Ranibizumab (Lucentis), and Aflibercept (Eylea) drugs. These medications are injected into the vitreous cavity of the eye, which decreases the leakage from the retinal blood vessels. A large number of patients receiving these treatments will need lifelong therapy at the intervals of 1-3 months.

A full report of Global Macular Degeneration Treatment Market Is available at https://www.omrglobal.com/industry-reports/macular-degeneration-treatment-market

Global Macular Degeneration Treatment Market Segmentation

By Type
• Dry Age-Related Macular Degeneration
• Wet Age-Related Macular Degeneration

By Route of Administration
• Intravitreal
• Intravenous

By Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Regional Analysis

• North America
o United States
o Canada

• Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe

• Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific

• Rest of the World

Company Profiles
• Alkahest, Inc.
• Allergan plc
• Amgen Inc.
• Bausch Health Companies Inc.
• Boehringer Ingelheim GmbH
• Clearside Biomedical, Inc.
• Exonate Ltd.
• F. Hoffman La-Roche AG
• Gemini Therapeutics, Inc.
• IVERIC bio, Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/macular-degeneration-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.